Association of malignant ascites with systemic inflammation and muscle loss after treatment in advanced‐stage ovarian cancer
Abstract Background Malignant ascites is prevalent in advanced‐stage ovarian cancer and may facilitate identification of the drivers of muscle loss. This study aimed to evaluate the association of ascites with changes in systemic inflammation and muscle after treatment of advanced‐stage ovarian canc...
Saved in:
Main Authors: | Chia‐Sui Weng (Author), Wan‐Chun Huang (Author), Chih‐Long Chang (Author), Ya‐Ting Jan (Author), Tze‐Chien Chen (Author), Jie Lee (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced‐stage ovarian cancer
by: Chueh‐Yi Huang, et al.
Published: (2020) -
Explainable machine learning model for predicting skeletal muscle loss during surgery and adjuvant chemotherapy in ovarian cancer
by: Wen‐Han Hsu, et al.
Published: (2023) -
Emerging treatment options for management of malignant ascites in patients with ovarian cancer
by: Eskander RN, et al.
Published: (2012) -
Antitumor effects of BMS-777607 on ovarian cancer cells with constitutively activated c-MET
by: Chao-Chih Wu, et al.
Published: (2019) -
Integrated miRNA Profiling of Extracellular Vesicles from Uterine Aspirates, Malignant Ascites and Primary-Cultured Ascites Cells for Ovarian Cancer Screening
by: Gleb O. Skryabin, et al.
Published: (2024)